Start › Rak jajnika › Wirginia › Arlington
Badania kliniczne dla Rak jajnika w mieście Arlington, VA
46 badań dla Rak jajnika szuka uczestników w ośrodkach w mieście Arlington i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekrutacjaZapraszamy zdrowych ochotników
- Inova Schar Cancer Institute, Fairfax · 11 mi dalej
- Inova Fair Oaks Hospital, Fairfax · 11 mi dalej
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekrutacjaFaza 2
- Inova Fairfax Hospital, Falls Church · 4 mi dalej
- Inova Schar Cancer Institute, Fairfax · 11 mi dalej
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RekrutacjaFaza 1/2
- Research Site, Fairfax · 11 mi dalej
A Study of PHST001 in Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT Oncology - Virginia, Fairfax · 11 mi dalej
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Inova Schar Cancer Institute, Fairfax · 11 mi dalej
- NEXT Virginia, Fairfax · 11 mi dalej
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekrutacjaFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekrutacjaFaza 1
- NEXT Virginia, Fairfax · 11 mi dalej
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
RekrutacjaFaza 2
- Next Virginia /ID# 279684, Fairfax · 11 mi dalej
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekrutacjaFaza 1
- Site 04, Fairfax · 11 mi dalej
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
RekrutacjaFaza 1
- Next Virginia /ID# 278607, Fairfax · 11 mi dalej
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
RekrutacjaFaza 1/2
- NEXT Virginia, Fairfax · 11 mi dalej
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RekrutacjaFaza 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · 11 mi dalej
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
RekrutacjaFaza 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · 11 mi dalej
Study of AVZO-021 in Patients With Advanced Solid Tumors
RekrutacjaFaza 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi dalej
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekrutacjaFaza 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi dalej
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekrutacjaFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
RekrutacjaFaza 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · 11 mi dalej
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekrutacjaFaza 1/2
- NEXT Oncology, Fairfax · 11 mi dalej
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekrutacjaFaza 3
- Inova Schar Cancer Institute, Fairfax · 11 mi dalej
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekrutacjaFaza 2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
RekrutacjaFaza 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mi dalej
- Next Oncology Virginia, Fairfax · 11 mi dalej
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekrutacjaFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
RekrutacjaFaza 1
- NEXT Oncology, Fairfax · 11 mi dalej
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RekrutacjaFaza 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · 11 mi dalej
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekrutacjaFaza 1
- Inova Schar Cancer Institute, Falls Church · 4 mi dalej
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekrutacjaFaza 1
- Normunity Investigational Site, Fairfax · 11 mi dalej
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekrutacja
- Inova Fairfax Hospital, Falls Church · 4 mi dalej
- Inova Schar Cancer Institute, Fairfax · 11 mi dalej
- Inova Fair Oaks Hospital, Fairfax · 11 mi dalej
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RekrutacjaFaza 1/2
- Clinical Trial Site, Fairfax · 11 mi dalej
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekrutacjaFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi dalej
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekrutacjaFaza 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mi dalej
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT Virginia, Fairfax · 11 mi dalej
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekrutacjaFaza 2
- 522, Fairfax · 11 mi dalej
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekrutacjaFaza 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi dalej
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
RekrutacjaFaza 1
- NEXT Virginia, Fairfax · 11 mi dalej
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekrutacjaFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekrutacjaFaza 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi dalej
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RekrutacjaFaza 1/2
- NEXT, Fairfax · 11 mi dalej
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RekrutacjaFaza 3
- Inova Schar Cancer Institute, Fairfax · 11 mi dalej
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RekrutacjaFaza 1
- NEXT Oncology Virginia, Fairfax · 11 mi dalej
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekrutacjaFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
RekrutacjaFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi dalej
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT Oncology, Fairfax · 11 mi dalej
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekrutacjaFaza 1
- Dren Investigational Site, Fairfax · 11 mi dalej
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
RekrutacjaFaza 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mi dalej
Badania dla Rak jajnika w innych miastach
- Houston, TX89 badań
- New York City, NY69 badań
- Boston, MA61 badań
- Los Angeles, CA50 badań
- Nashville, TN49 badań
- Philadelphia, PA44 badań
- Columbus, OH39 badań
- St. Louis, MO38 badań
- Chicago, IL36 badań
- San Antonio, TX31 badań
- Cleveland, OH30 badań
- Pittsburgh, PA30 badań
Inne badania w mieście Arlington
- Niedrobnokomórkowy rak płuca104 badań
- Nowotwór przerzutowy53 badań
- Rak jelita grubego i odbytnicy52 badań
- Nowotwory (wszystkie typy)48 badań
- Rak piersi47 badań
- Rak płuc41 badań
- Rak endometrium39 badań
- Rak trzustki33 badań
- Rak płaskonabłonkowy głowy i szyi26 badań
- Niedrobnokomórkowy rak płuca23 badań
- Nowotwór żołądka20 badań
- Rak piersi potrójnie ujemny20 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.